Permira of London and TPG of San Francisco, California, have bought stakes in Cloudnine Hospitals, a maternity and child care chain based in Bengaluru, in southern India. Mint reported the $450 million deal on September 29, citing two people familiar with the matter, and said it values Cloudnine at $1.3...
DoorDash Opens Hyderabad Hub With 500 Employees
DoorDash, the local commerce platform based in San Francisco, California, has opened a hub in Hyderabad, in southern India, with 500 employees. The company plans to grow the team to more than 3,000 over the next two years, The Hindu BusinessLine reported. The Hyderabad team will start with customer experience...
Uber Invests $10 Million in India Fleet Partner Carrum Mobility
Uber, headquartered in San Francisco, California, has invested $10 million in Carrum Mobility, a fleet management startup based in Gurgaon, Haryana in the Delhi National Capital Region. The Series B round values Carrum at $168 million, nearly tripling the roughly $63 million valuation the company carried after Uber's first $7...
Air India to Launch Nonstop Flights to Los Angeles, Seattle, Dallas
Air India is the only Indian airline currently operating flights to the United States, with services to Washington, New York, Newark, San Francisco, and Chicago. As part of its consolidation efforts, including a proposed merger with Vistara, Air India is looking to expand its U.S. operations by launching direct flights...
IPEF Group, U.S., Sign Supply Chain Resilience Pact
The United States, India, and 12 other members of the Indo-Pacific Economic Framework for Prosperity (IPEF) have signed a supply chain resilience agreement. Australia, Brunei Darussalam, Fiji, India, Indonesia, Japan, Republic of Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, the US and Vietnam are members of the bloc. Under the...
Dr. Reddy’s Partners with Olema Pharma
San Francisco-based Olema and Aurigene Discovery Technologies, a wholly-owned unit of Dr. Reddy's Laboratories of Hyderabad, India have inked an exclusive global license agreement to research, develop, and commercialize novel small molecule inhibitors of an undisclosed oncology target. Under the terms of the agreement, Olema will make an upfront licensing...